Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 140 entries
Sorted by: Best Match Show Resources per page
[Breast and Endocrine Tumor Recent Trend of Antibody-Drug Conjugate for Breast Cancer].

Gan to kagaku ryoho. Cancer & chemotherapy

Saeki T.
PMID: 34911908
Gan To Kagaku Ryoho. 2021 Dec;48(12):1447.

No abstract available.

Cite
Saeki T. [Breast and Endocrine Tumor Recent Trend of Antibody-Drug Conjugate for Breast Cancer]. Gan To Kagaku Ryoho. 2021;48(12):1447
Saeki, T. (2021). [Breast and Endocrine Tumor Recent Trend of Antibody-Drug Conjugate for Breast Cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 48(12), 1447.
Saeki, Toshiaki. "[Breast and Endocrine Tumor Recent Trend of Antibody-Drug Conjugate for Breast Cancer]." Gan to kagaku ryoho. Cancer & chemotherapy vol. 48,12 (2021): 1447.
Saeki T. [Breast and Endocrine Tumor Recent Trend of Antibody-Drug Conjugate for Breast Cancer]. Gan To Kagaku Ryoho. 2021 Dec;48(12):1447. Japanese. PMID: 34911908.
Copy Download .nbib Format: NLM
[Ⅰ. Clinical Development and Biological/Pharmacological Characteristics of Monoclonal Antibody in Oncology].

Gan to kagaku ryoho. Cancer & chemotherapy

Ishiguro H.
PMID: 34911909
Gan To Kagaku Ryoho. 2021 Dec;48(12):1448-1451.

No abstract available.

Cite
Ishiguro H. [Ⅰ. Clinical Development and Biological/Pharmacological Characteristics of Monoclonal Antibody in Oncology]. Gan To Kagaku Ryoho. 2021;48(12):1448-1451
Ishiguro, H. (2021). [Ⅰ. Clinical Development and Biological/Pharmacological Characteristics of Monoclonal Antibody in Oncology]. Gan to kagaku ryoho. Cancer & chemotherapy, 48(12), 1448-1451.
Ishiguro, Hiroshi. "[Ⅰ. Clinical Development and Biological/Pharmacological Characteristics of Monoclonal Antibody in Oncology]." Gan to kagaku ryoho. Cancer & chemotherapy vol. 48,12 (2021): 1448-1451.
Ishiguro H. [Ⅰ. Clinical Development and Biological/Pharmacological Characteristics of Monoclonal Antibody in Oncology]. Gan To Kagaku Ryoho. 2021 Dec;48(12):1448-1451. Japanese. PMID: 34911909.
Copy Download .nbib Format: NLM
[Ⅱ. Application for HER2-Positive Breast Cancer(Trastuzumab Deruxtecan)].

Gan to kagaku ryoho. Cancer & chemotherapy

Naito Y.
PMID: 34911910
Gan To Kagaku Ryoho. 2021 Dec;48(12):1452-1453.

No abstract available.

Cite
Naito Y. [Ⅱ. Application for HER2-Positive Breast Cancer(Trastuzumab Deruxtecan)]. Gan To Kagaku Ryoho. 2021;48(12):1452-1453
Naito, Y. (2021). [Ⅱ. Application for HER2-Positive Breast Cancer(Trastuzumab Deruxtecan)]. Gan to kagaku ryoho. Cancer & chemotherapy, 48(12), 1452-1453.
Naito, Yoichi. "[Ⅱ. Application for HER2-Positive Breast Cancer(Trastuzumab Deruxtecan)]." Gan to kagaku ryoho. Cancer & chemotherapy vol. 48,12 (2021): 1452-1453.
Naito Y. [Ⅱ. Application for HER2-Positive Breast Cancer(Trastuzumab Deruxtecan)]. Gan To Kagaku Ryoho. 2021 Dec;48(12):1452-1453. Japanese. PMID: 34911910.
Copy Download .nbib Format: NLM
[Successful Control of Hyperammonemia with BRTO of a Splenorenal Shunt Induced by CAPOX Therapy].

Gan to kagaku ryoho. Cancer & chemotherapy

Hori Y, Irei T, Harada T, Yamashiro N, Motonari H, Kinjo N, Arakaki J, Samura H, Kameyama S, Nagamine Y, Kohakura F, Ishimine T, Tsuruta Y, Matsuzaki A.
PMID: 34911920
Gan To Kagaku Ryoho. 2021 Dec;48(12):1507-1510.

Among portosystemic shunts, splenorenal shunts can cause increased portal pressure, which in turn can bring about hyperammonemia, resulting in hepatic encephalopathy. In recent years, it has been reported that oxaliplatin(OX), a key chemotherapy drug in colorectal cancer, can precipitate...

Cite
Hori Y, Irei T, Harada T, et al. [Successful Control of Hyperammonemia with BRTO of a Splenorenal Shunt Induced by CAPOX Therapy]. Gan To Kagaku Ryoho. 2021;48(12):1507-1510
Hori, Y., Irei, T., Harada, T., Yamashiro, N., Motonari, H., Kinjo, N., Arakaki, J., Samura, H., Kameyama, S., Nagamine, Y., Kohakura, F., Ishimine, T., Tsuruta, Y., & Matsuzaki, A. (2021). [Successful Control of Hyperammonemia with BRTO of a Splenorenal Shunt Induced by CAPOX Therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 48(12), 1507-1510.
Hori, Yoshiki, et al. "[Successful Control of Hyperammonemia with BRTO of a Splenorenal Shunt Induced by CAPOX Therapy]." Gan to kagaku ryoho. Cancer & chemotherapy vol. 48,12 (2021): 1507-1510.
Hori Y, Irei T, Harada T, Yamashiro N, Motonari H, Kinjo N, Arakaki J, Samura H, Kameyama S, Nagamine Y, Kohakura F, Ishimine T, Tsuruta Y, Matsuzaki A. [Successful Control of Hyperammonemia with BRTO of a Splenorenal Shunt Induced by CAPOX Therapy]. Gan To Kagaku Ryoho. 2021 Dec;48(12):1507-1510. Japanese. PMID: 34911920.
Copy Download .nbib Format: NLM
[Management of Cancer Genomic Board and Preparation of Genomic Report].

Gan to kagaku ryoho. Cancer & chemotherapy

Nakamura K, Nishihara H.
PMID: 32829344
Gan To Kagaku Ryoho. 2020 Aug;47(8):1141-1148.

The accumulation of gene alteration is the major pathogenicity of any types of cancer. The concept of precision cancer medicine is therefore the individualized treatment based on the driver gene alteration in each case. The cancer gene profiling (CGP)...

Cite
Nakamura K, Nishihara H. [Management of Cancer Genomic Board and Preparation of Genomic Report]. Gan To Kagaku Ryoho. 2020;47(8):1141-1148
Nakamura, K., & Nishihara, H. (2020). [Management of Cancer Genomic Board and Preparation of Genomic Report]. Gan to kagaku ryoho. Cancer & chemotherapy, 47(8), 1141-1148.
Nakamura, Kohei, and Nishihara, Hiroshi. "[Management of Cancer Genomic Board and Preparation of Genomic Report]." Gan to kagaku ryoho. Cancer & chemotherapy vol. 47,8 (2020): 1141-1148.
Nakamura K, Nishihara H. [Management of Cancer Genomic Board and Preparation of Genomic Report]. Gan To Kagaku Ryoho. 2020 Aug;47(8):1141-1148. Japanese. PMID: 32829344.
Copy Download .nbib Format: NLM
[Current Issues and Future Perspectives of Biosimilar in Cancer Therapy].

Gan to kagaku ryoho. Cancer & chemotherapy

Yonezawa A, Matsubara K.
PMID: 32381902
Gan To Kagaku Ryoho. 2020 Mar;47(3):397-401.

Several biosimilars have appeared in cancer treatment. They should contribute to the reduction of medical cost. However, in Japan, a suspicion of medical staffs and patients to biosimilars and an obstruction of High-Cost Medical Expense Benefit to the burden...

Cite
Yonezawa A, Matsubara K. [Current Issues and Future Perspectives of Biosimilar in Cancer Therapy]. Gan To Kagaku Ryoho. 2020;47(3):397-401
Yonezawa, A., & Matsubara, K. (2020). [Current Issues and Future Perspectives of Biosimilar in Cancer Therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 47(3), 397-401.
Yonezawa, Atsushi, and Matsubara, Kazuo. "[Current Issues and Future Perspectives of Biosimilar in Cancer Therapy]." Gan to kagaku ryoho. Cancer & chemotherapy vol. 47,3 (2020): 397-401.
Yonezawa A, Matsubara K. [Current Issues and Future Perspectives of Biosimilar in Cancer Therapy]. Gan To Kagaku Ryoho. 2020 Mar;47(3):397-401. Japanese. PMID: 32381902.
Copy Download .nbib Format: NLM
[Home Care for Cancer Patients and Outreach from the Hospital].

Gan to kagaku ryoho. Cancer & chemotherapy

Ogino M.
PMID: 32381905
Gan To Kagaku Ryoho. 2020 Mar;47(3):413-416.

Japan is entering a multi-dying era. In this situation palliative care is increasingly important. More than half of Japanese state that they want to stay at home even when facing the end of life, especially in cancer area. But...

Cite
Ogino M. [Home Care for Cancer Patients and Outreach from the Hospital]. Gan To Kagaku Ryoho. 2020;47(3):413-416
Ogino, M. (2020). [Home Care for Cancer Patients and Outreach from the Hospital]. Gan to kagaku ryoho. Cancer & chemotherapy, 47(3), 413-416.
Ogino, Mieko. "[Home Care for Cancer Patients and Outreach from the Hospital]." Gan to kagaku ryoho. Cancer & chemotherapy vol. 47,3 (2020): 413-416.
Ogino M. [Home Care for Cancer Patients and Outreach from the Hospital]. Gan To Kagaku Ryoho. 2020 Mar;47(3):413-416. Japanese. PMID: 32381905.
Copy Download .nbib Format: NLM
[Upper G. I. Cancer].

Gan to kagaku ryoho. Cancer & chemotherapy

Terashima M.
PMID: 34521786
Gan To Kagaku Ryoho. 2021 Sep;48(9):1109.

No abstract available.

Cite
Terashima M. [Upper G. I. Cancer]. Gan To Kagaku Ryoho. 2021;48(9):1109
Terashima, M. (2021). [Upper G. I. Cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 48(9), 1109.
Terashima, Masanori. "[Upper G. I. Cancer]." Gan to kagaku ryoho. Cancer & chemotherapy vol. 48,9 (2021): 1109.
Terashima M. [Upper G. I. Cancer]. Gan To Kagaku Ryoho. 2021 Sep;48(9):1109. Japanese. PMID: 34521786.
Copy Download .nbib Format: NLM
[The significance of assessment of quality of life as a cancer treatment].

Gan to kagaku ryoho. Cancer & chemotherapy

Hinotsu A, Miyanaga N, Akaza H.
PMID: 12146018
Gan To Kagaku Ryoho. 2002 Jul;29(7):1319-24.

Now that cancer treatments have advanced and people are surviving longer, considerations of patient QOL are becoming more important. QOL questionnaires are lists of questions taken from more than two domains. The questions are roughly divided into the "general...

Cite
Hinotsu A, Miyanaga N, Akaza H. [The significance of assessment of quality of life as a cancer treatment]. Gan To Kagaku Ryoho. 2002;29(7):1319-24
Hinotsu, A., Miyanaga, N., & Akaza, H. (2002). [The significance of assessment of quality of life as a cancer treatment]. Gan to kagaku ryoho. Cancer & chemotherapy, 29(7), 1319-24.
Hinotsu, Atsuko, et al. "[The significance of assessment of quality of life as a cancer treatment]." Gan to kagaku ryoho. Cancer & chemotherapy vol. 29,7 (2002): 1319-24.
Hinotsu A, Miyanaga N, Akaza H. [The significance of assessment of quality of life as a cancer treatment]. Gan To Kagaku Ryoho. 2002 Jul;29(7):1319-24. Japanese. PMID: 12146018.
Copy Download .nbib Format: NLM
[Supporting the Balance between Work and Treatment for Cancer Patients by Career Consultants Aiming for Reconstruction of Work Life].

Gan to kagaku ryoho. Cancer & chemotherapy

Hattori F.
PMID: 31631125
Gan To Kagaku Ryoho. 2019 Oct;46(10):1482-1485.

In order to support the balance between work and treatment for cancer patients, the viewpoint of "Reconstruction of work life" would be essential. Conflicts after getting back to work can be prevented bythoroughlyunderstanding how patients with mental and physical...

Cite
Hattori F. [Supporting the Balance between Work and Treatment for Cancer Patients by Career Consultants Aiming for Reconstruction of Work Life]. Gan To Kagaku Ryoho. 2019;46(10):1482-1485
Hattori, F. (2019). [Supporting the Balance between Work and Treatment for Cancer Patients by Career Consultants Aiming for Reconstruction of Work Life]. Gan to kagaku ryoho. Cancer & chemotherapy, 46(10), 1482-1485.
Hattori, Fumi. "[Supporting the Balance between Work and Treatment for Cancer Patients by Career Consultants Aiming for Reconstruction of Work Life]." Gan to kagaku ryoho. Cancer & chemotherapy vol. 46,10 (2019): 1482-1485.
Hattori F. [Supporting the Balance between Work and Treatment for Cancer Patients by Career Consultants Aiming for Reconstruction of Work Life]. Gan To Kagaku Ryoho. 2019 Oct;46(10):1482-1485. Japanese. PMID: 31631125.
Copy Download .nbib Format: NLM
[Endocrine Dysfunction Associated with Immune Checkpoint Blockade].

Gan to kagaku ryoho. Cancer & chemotherapy

Iwama S.
PMID: 32381947
Gan To Kagaku Ryoho. 2020 Feb;47(2):203-206.

Immune checkpoint inhibitors(ICIs)have been widely used in patients with advanced malignancies. However, these drugs can cause immune-related adverse events(irAEs)in several organs, including lung, skin, gastrointestinal tract, liver, nerve, muscle, and endocrine organs. Endocrine irAEs include hypopituitarism, primary adrenal insufficiency,...

Cite
Iwama S. [Endocrine Dysfunction Associated with Immune Checkpoint Blockade]. Gan To Kagaku Ryoho. 2020;47(2):203-206
Iwama, S. (2020). [Endocrine Dysfunction Associated with Immune Checkpoint Blockade]. Gan to kagaku ryoho. Cancer & chemotherapy, 47(2), 203-206.
Iwama, Shintaro. "[Endocrine Dysfunction Associated with Immune Checkpoint Blockade]." Gan to kagaku ryoho. Cancer & chemotherapy vol. 47,2 (2020): 203-206.
Iwama S. [Endocrine Dysfunction Associated with Immune Checkpoint Blockade]. Gan To Kagaku Ryoho. 2020 Feb;47(2):203-206. Japanese. PMID: 32381947.
Copy Download .nbib Format: NLM
[Overcoming Fear of Death in Home Caregiving].

Gan to kagaku ryoho. Cancer & chemotherapy

Hiyoshi K, Becker C, Fukuyama H, Oishi N.
PMID: 31189864
Gan To Kagaku Ryoho. 2019 May;46:84-86.

This study aimed to clarify the factors for reducing the burden of caregivers caring for terminal patients. We conducted semi-structured interviews with bereaved caregivers, seeking those who had felt neither fear nor anxiety during caregiving; their responses were analyzed...

Cite
Hiyoshi K, Becker C, Fukuyama H, et al. [Overcoming Fear of Death in Home Caregiving]. Gan To Kagaku Ryoho. 2019;46:84-86
Hiyoshi, K., Becker, C., Fukuyama, H., & Oishi, N. (2019). [Overcoming Fear of Death in Home Caregiving]. Gan to kagaku ryoho. Cancer & chemotherapy, 4684-86.
Hiyoshi, Kazuko, et al. "[Overcoming Fear of Death in Home Caregiving]." Gan to kagaku ryoho. Cancer & chemotherapy vol. 46 (2019): 84-86.
Hiyoshi K, Becker C, Fukuyama H, Oishi N. [Overcoming Fear of Death in Home Caregiving]. Gan To Kagaku Ryoho. 2019 May;46:84-86. Japanese. PMID: 31189864.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 140 entries